Non-cGMP API Starting Materials + Non-cGMP API Pilot Plant – Asset Opportunity
We have a Non-cGMP API starting material company with operations in Jaipur, India and Birmingham, Alabama.
14 years old, $33 Million in 2021 sales, $20 million EBITDA.
120 staff, long term relationships with US / Japanese client base.
I’m looking for x9 EBITDA.
+ Privately-owned Active Pharmaceutical Ingredient (API)
company developing and manufacturing complex API’s, with
deep expertise in Medicinal Chemistry and Drug Discovery.
+ Leadership Team with diverse industry experience across both
facilities in India and North America.
+ 2021 Revenue of $31-34 Million, with a 61% EBITDA, delivering
$20 Million bottom line.
+ 9,100 ft² facility with R&D labs and newly constructed cGMP
Suite in USA.
+ 48,000 ft² R&D labs, non-GMP Pilot and Manufacturing Plants
for pre-clinical material and 37,000 ft² for expansion in India.
+ This company serves a client base which includes publicly listed
US biotech companies and big pharma based in Asia-Pacific.
+ 110 FTEs, with 10 PhD, 45 MSc, 10 BSc, working across both
Indian and North American locations.
+ 20% projected growth over the next 3 years with a sustained
and supported EBITDA to match.
+ Please request the CIM after Fully Executed NDA.